Viewing nowGlipiron 2 mg (Glymepiride)
Glimepiride 2mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.

MFDS item code 201306343 · Approved 2013.03.21 · Insurance code 649404550
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used as an adjunct to dietary management and exercise to aid in blood sugar control in patients with type 2 diabetes. It can be used alone, and when adequate blood sugar control cannot be achieved with oral hypoglycemic agents or insulin therapy, it can be used in combination to enhance effectiveness. In particular, this medication can be added when blood sugar control is inadequate during treatment with sulfonylureas or metformin alone, providing good results. Thus, this medication assists in improving blood sugar control in patients with type 2 diabetes in various treatment situations.
The dose should be adjusted individually for each patient. Swallow whole without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose determination For patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional effect with doses greater than 4 mg, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Secondary dose adjustment As diabetes control may improve during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered when weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previous medicine should be considered. 4) Dose adjustment during treatment Blood glucose and/or urine glucose levels should be measured regularly while taking this medicine, and regular measurement of glycosylated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur despite successful initial management when a sulfonylurea is administered. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycosylated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy with metformin and other sulfonylureas such as glyburide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be used in patients with type 1 diabetes or those with diabetic ketoacidosis or coma. Additionally, individuals allergic to this medication or to sulfonylureas and sulfonamides should not take it. In patients with severely impaired liver or kidney function, switching to insulin therapy is recommended instead of using this medication. Pregnant women or those who may become pregnant, as well as breastfeeding women, should refrain from taking this medication. Patients with severe infections, those undergoing surgery, or those who have sustained significant injuries are safer undergoing insulin therapy. In cases of gastrointestinal disturbances such as diarrhea or vomiting, care should be taken due to the risk of hypoglycemia resulting from improper food absorption. This medication contains lactose, hence individuals with lactose intolerance or certain genetic metabolic disorders should not take it. During the first week of taking the medication, the risk of hypoglycemia is increased, so blood sugar levels should be monitored closely. Especially elderly individuals, those with poor nutritional status or irregular eating habits, and those who do not align their physical activity with food intake should exercise greater caution. Patients who frequently consume alcohol or have diminished liver and kidney function are also at higher risk for hypoglycemia. Caution should be taken in cases with other endocrine diseases, overdose of this medication, or concurrent use of various medications. This medication contains Yellow No. 4 dye, and those allergic to this ingredient should use it cautiously. Hypoglycemia may occur, with symptoms including headache, severe hunger, nausea, fatigue, confusion, drowsiness, and decreased consciousness. If these symptoms occur, it is crucial to immediately consume sugar or seek medical assistance. Temporary blurred vision, gastrointestinal disorders, liver function abnormalities, blood disorders, and allergic reactions have also been reported. While taking this medication, maintaining regular meals, exercise, and weight management is important, and frequent monitoring of blood sugar levels is necessary. It is essential to be well-informed about the symptoms of hypoglycemia and to always carry sugar. When receiving treatment at another hospital, it is imperative to inform them about your diabetes status and medication history. In stressful situations such as infections, surgery, or trauma, transitioning to insulin therapy may be necessary. This medication is excreted via the kidneys, so elderly patients should adjust the dosage according to kidney function. In the case of overdose, severe hypoglycemia may occur, requiring immediate treatment at a medical facility, and inducing vomiting or gastric lavage may be necessary. This medication has not been proven safe or effective in children, and thus should not be used in pediatric patients. Taking this medication alongside other drugs may affect blood sugar control; therefore, it is essential to consult with healthcare providers. Finally, pregnant or breastfeeding women should ideally avoid this medication and consider switching to insulin therapy.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disturbances, anxiety, aggression, decreased concentration, decreased agility or initiative, depression, confusion, speech impairment, aphasia, visual impairment, tremors, partial paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cool and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a sealed container. It is important to maintain the storage temperature between 1 degree Celsius and 30 degrees Celsius at room temperature. This will help preserve the efficacy of the medication for a longer duration.
Green, oblong tablet
30 tablets/bottle, 200 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.